Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Colorcon
Boehringer Ingelheim
Merck
Johnson and Johnson

Last Updated: July 5, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 012911


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 012911 describes METOPIRONE, which is a drug marketed by Hra Pharma and is included in one NDA. Additional details are available on the METOPIRONE profile page.

The generic ingredient in METOPIRONE is metyrapone. There is one drug master file entry for this compound. Additional details are available on the metyrapone profile page.
Summary for 012911
Tradename:METOPIRONE
Applicant:Hra Pharma
Ingredient:metyrapone
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 012911

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength250MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength250MG
Approval Date:Aug 9, 1996TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Johnson and Johnson
Colorcon
Moodys
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.